Clinical studies recruiting near Regensburg

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Caritas-Krankenhaus St. Josef · Pfizer · NCT07028853 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Caritas-Krankenhaus St. Josef · Bristol-Myers Squibb · NCT07106762 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 6417 · Galderma R&D · NCT06988605 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · University Hospital Regensburg · Miltenyi Biomedicine GmbH · NCT04844866 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · Krankenhaus Barmherzige Brüder · AGO Study Group · NCT05009082 A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · Universitätsklinikum Regensburg · Pfizer · NCT07073820 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Universitätsklinikum Regensburg · Hoffmann-La Roche · NCT06793215 A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chr
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07549516 Endometrial Cancer Lymphadenectomy Trial
NA · Caritas-Krankenhaus St. Josef, Klinik für Frauenheilkunde u. · Philipps University Marburg · NCT03438474 Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Phase 3 · UNIVERSITATSKLINIKUM REGENSBURG - Klinik für Innere Medizin · The Lymphoma Academic Research Organisation · NCT06006117 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Lipidambulanz Uniklinikum Regensburg · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]
Phase 2 · Universität Regensburg, Klinik und Poliklinik für Strahlenth · University of Leipzig · NCT06137378 International HIT-MED Registry (I-HIT-MED)
Phase N/A · University Hospital Regensburg · Universitätsklinikum Hamburg-Eppendorf · NCT02417324 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Universitaetsklinikum Regensburg ( Site 1204) · Merck Sharp & Dohme LLC · NCT06077760 PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS
Phase N/A · Caritas-Krankenhaus St. Josef, Klinik für Frauenheilkunde & · Women's Cancer Study Group GmbH · NCT05792150 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Krankenhaus Barmherzige Brüder Regensburg · Goethe University · NCT02872987 RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NA · Universitätsklinikum Regensburg · AgNovos Healthcare, LLC · NCT04796350 Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Phase 1 · University Hospital Regensburg · Regeneron Pharmaceuticals · NCT06975787 Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic
Phase 2 · Research Site · AstraZeneca · NCT06535607 Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06517719 Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Ad
Phase 2 · Krankenhaus Barmherzige Brüder Regensburg · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT07176312 A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR
Phase 2 · UKR Innere Med II Pneumologie · Taiho Oncology, Inc. · NCT05967689 Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML
Phase 2 · Krankenhaus Barmherzige Brüder · Technische Universität Dresden · NCT05904106 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Phase N/A · University Hospital Regensburg · NovoCure Ltd. · NCT05538806 Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab
Phase 2 · Universitätsklinikum Regensburg · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT07387198 Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNS
Phase 3 · Universitätsklinikum Regensburg · University Hospital Freiburg · NCT06830421 A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).
Phase 3 · University Hospital Regensburg, Neurology Clinic · University Hospital Heidelberg · NCT05331521 Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of
Phase 3 · Research Site · AstraZeneca · NCT06921785 Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders
Phase N/A · University of Regensburg · Dr. Rebecca Schule · NCT03981276

Look up another city

Look up another condition